Lung cancer therapy may improve outcomes of metastatic brain cancer
Medications commonly used to treat non-small cell lung cancer that has metastasized may have therapeutic benefits for patients with metastatic brain cancers.... Read More...
EGFR
Unexpected connection between gliomas and neurodegenerative diseases
Study finds significant expression of the Alzheimer's related Tau protein in glioma cells, especially in patients with better prognoses.... Read More...
Non-coding DNA located outside chromosomes may help drive glioblastoma
Extra DNA is critical for maintaining cancer-causing gene activation and supporting the cancer cell's ability to survive.... Read More...
Adding MS drug to targeted cancer therapy may improve glioblastoma outcomes
Teriflunomide, a drug commonly used to treat multiple sclerosis, shows promise for the treatment of glioblastoma when coupled with targeted cancer therapies.... Read More...
Study hints at why an aggressive form of brain cancer is hard to treat
Genetics and microenvironment influence the frequency of glioblastoma cells. Researchers provide a new blueprint for glioblastoma, integrating the malignant cell programs, cancer cell plasticity, and modulation by genetic drivers. The findings shed light on why this form of cancer is so hard to treat effectively.... Read More...
A Potential Achilles Heel in Brain Cancer
A new study in PNAS reports blocking the expression of MDA-9/Syntenin forces glioma stem cells to lose their ability to induce protective autophagy.... Read More...
To Sleep or Not to Sleep: The Complex Genetic Network Behind Sleep Duration
NIH researchers have identified a set of genes they believe could explain why some people need more, or less, sleep that others. The findings could help to develop new treatments for a variety of sleep disorders from insomnia to narcolepsy.... Read More...
New Approach to Destroying Deadly Brain Tumors
Researchers at UT Southwestern report medications used to treat arthritis and lung cancer may help in the battle against glioblastoma.... Read More...
Combination Treatment Targeting Glucose in Advanced Brain Cancer Shows Promising Results in Preclinical Study
UCLA researchers report erlotinib, an FDA approved drug, reduces glucose uptake in glioblastoma, effectively cutting off nutrients and energy supply to the tumor.... Read More...
Study Splits Incurable Childhood Brain Tumors Into 10 New Diseases
Based on a large scale meta analysis, researchers report striking differences between children's high grade gliomas, so much so that they could be split into 10 different subtypes based on different characteristics. The findings have important implications for developing new and individualized treatments. ... Read More...
CD44s Gives Glioblastoma Brain Cancer a Survival Advantage
A new Baylor study reveals the CD44s molecule gives glioblastoma brain cancer cells a survival advantage. Removing CD44s from cancer cells and treating with erlotinib helped to promote the death of cancer cells than by just treating the cancer with erlotinib alone, researchers said.... Read More...
How Neurons and Glia Cells Are Created in the Developing Brain
Researchers have identified a gene that plays a vital role in the production of neurons and glial cells in the brain.... Read More...